Pages that link to "Q38086743"

The following pages link to Protein fibrillation and nanoparticle interactions: opportunities and challenges (Q38086743):

Displaying 27 items.

• Dimensionality of carbon nanomaterials determines the binding and dynamics of amyloidogenic peptides: multiscale theoretical simulations (Q28392405) (← links)
• Effects of hydroxylated carbon nanotubes on the aggregation of Aβ16-22 peptides: a combined simulation and experimental study (Q34423854) (← links)
• Amyloid transition of ubiquitin on silver nanoparticles produced by pulsed laser ablation in liquid as a function of stabilizer and single-point mutations. (Q35212808) (← links)
• How Do the Size, Charge and Shape of Nanoparticles Affect Amyloid β Aggregation on Brain Lipid Bilayer? (Q36500158) (← links)
• Influence of gold nanoparticle surface chemistry and diameter upon Alzheimer's disease amyloid-β protein aggregation. (Q37625885) (← links)
• Nanomaterials for reducing amyloid cytotoxicity (Q38110699) (← links)
• Amyloid-based therapies did fail again! It is the right time to change our vision on building block of Alzheimer's disease (Q38544118) (← links)
• Theranostic potential of gold nanoparticle-protein agglomerates. (Q38617939) (← links)
• Biosafety evaluations of well-dispersed mesoporous silica nanoparticles: towards in vivo-relevant conditions. (Q39025870) (← links)
• Antibody-conjugated, dual-modal, near-infrared fluorescent iron oxide nanoparticles for antiamyloidgenic activity and specific detection of amyloid-β fibrils (Q39066716) (← links)
• Gold-Induced Fibril Growth: The Mechanism of Surface-Facilitated Amyloid Aggregation (Q39500053) (← links)
• Protein corona composition of gold nanoparticles/nanorods affects amyloid beta fibrillation process (Q41392590) (← links)
• Evaluation of nonspecific interactions between quantum dots and proteins (Q42230017) (← links)
• The molecular mechanism of fullerene-inhibited aggregation of Alzheimer's β-amyloid peptide fragment. (Q45207430) (← links)
• Fibrillation-prone conformations of the amyloid-β-42 peptide at the gold/water interface. (Q45968145) (← links)
• Modulating protein amyloid aggregation with nanomaterials. (Q47259639) (← links)
• Plasma protein adsorption and biological identity of systemically administered nanoparticles (Q47570893) (← links)
• Increase in the β-Sheet Character of an Amyloidogenic Peptide upon Adsorption onto Gold and Silver Surfaces. (Q48050794) (← links)
• Biogenic synthesis of gold nanoparticles from Terminalia arjuna bark extract: assessment of safety aspects and neuroprotective potential via antioxidant, anticholinesterase, and antiamyloidogenic effects (Q50195753) (← links)
• The interaction with gold suppresses fiber-like conformations of the amyloid β (16–22) peptide (Q57952194) (← links)
• Direct Observation of Amyloid Behavior at Phospholipid Membrane Constructed on Gold Nanoparticles (Q60921584) (← links)
• The viral protein corona directs viral pathogenesis and amyloid aggregation (Q64286426) (← links)
• Pristine and Hydroxylated Fullerenes Prevent the Aggregation of Human Islet Amyloid Polypeptide and Display Different Inhibitory Mechanisms (Q89967373) (← links)
• Inhibition of Glycation-Induced Aggregation of Human Serum Albumin by Organic-Inorganic Hybrid Nanocomposites of Iron Oxide-Functionalized Nanocellulose (Q90267946) (← links)
• Carbon Nanoparticles Inhibit the Aggregation of Prion Protein as Revealed by Experiments and Atomistic Simulations (Q90692094) (← links)
• Self-assembly of plant protein fibrils interacting with superparamagnetic iron oxide nanoparticles (Q92919395) (← links)
• Effect of Terminal Modifications on the Adsorption and Assembly of hIAPP(20-29) (Q92942047) (← links)